Science

2019

Comparison of bone lesion distribution between prostate cancer and multiple myeloma with whole-body MRI

Larbi A, Omoumi P, Pasoglou V, Michoux N, Triqueneaux P, Tombal B, Cyteval C, Lecouvet FE

Journal: Diagnostic and Interventional Imaging
Volume: 100, Issue 5
Année: Mai 2019
Pages: 295-302

https://doi.org/10.1016/j.diii.2018.12.005

Bone metastases from lung cancer: A paradigm for multidisciplinary onco-rheumatology management

Confavreux CB, Pialat JB, Bellière A, Brevet M, Decroisette C, Tescaru A, Wegrzyn J, Barrey C, Mornex F, Souquet PJ, Girard N

Journal: Joint Bone Spine
Volume: 86, Issue 2
Année: Mars 2019
Pages: 185-194

https://doi.org/10.1016/j.jbspin.2018.03.005

A real-world study assessing the use of bone-targeted agents and their impact on bone metastases in patients with prostate cancer treated in clinical practice in Europe

Body JJ, von Moos R, Rider A, Hallworth P, Bhowmik D, Gatta F, Hechmati G, Qian Y

Journal: Journal of Bone Oncology
Volume: 14
Année: Février 2019
Pages:100212

https://doi.org/10.1016/j.jbo.2018.100212

French recommendations for osteoporosis prevention and treatment in patients with prostate cancer treated by androgen deprivation

Briot K, Paccou J, Beuzeboc P, Bonneterre J, Bouvard B, Confavreux CB, Cormier C, Cortet B, Hannoun-Lévi JM, Hennequin C, Javier RM, Lespessailles E, Mayeur D, Mongiat Artus P, Vieillard MH, Debiais F

Journal: Joint Bone Spine
Volume: 86, Issue 1
Année: Janvier 2019
Pages: 21-28

https://doi.org/10.1016/j.jbspin.2018.09.017

2018

TMPRSS2:ERG gene fusion expression regulates bone markers and enhances the osteoblastic phenotype of prostate cancer bone metastases

Delliaux C, Tian TV, Bouchet M, Fradet A, Vanpouille N, Florens A, Deplus R, Villers A, Leroy X, Clézardin P, De Launoit Y, Bonnelye E, Duterque-Coquillaud M

Journal: Cancer Letters
Volume: 438
Année: Décembre 2018
Pages: 32-43

https://doi.org/10.1016/j.canlet.2018.08.027

Hypocalcaemia in patients with prostate cancer treated with a bisphosphonate or denosumab: prevention supports treatment completion

Body JJ, von Moos R, Niepel D, Tombal B

Journal: BMC Urology
Volume: 18, Issue 1
Année: Septembre 2018
Pages: 81

https://doi.org/10.1186/s12894-018-0393-9

Isolation of circulating tumor cells in a preclinical model of osteosarcoma: Effect of chemotherapy

Chalopin A, Tellez-Gabriel M, Brown HK, Vallette F, Heymann MF, Gouin F, Heymann D

Journal: Journal of Bone Oncology
Volume: 12
Année: Septembre 2018
Pages: 83-90

https://doi.org/10.1016/j.jbo.2018.07.002

Paradoxical side effects of bisphosphonates on the skeleton: What do we know and what can we do?

Vargas-Franco JW, Castaneda B, Rédiní F, Gómez DF, Heymann D, Lézot F

Journal: Journal of Cellular Physiology
Volume: 233, Issue 8
Année: Août 2018
Pages: 5696-5715

https://doi.org/10.1002/jcp.26465

Bidirectional regulation of bone formation by exogenous and osteosarcoma-derived Sema3A

de Ridder D, Marino S, Bishop RT, Renema N, Chenu C, Heymann D, Idris AI

Journal: Scientific Reports
Volume: 8, Issue 1
Année: Mai 2018
Pages: 6877

https://doi.org/10.1038/s41598-018-25290-2